Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.76 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.55 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.37 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.37 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.35 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9875915 | 1.00 | ALDH1A1 (0.76) | ALDH1A1TDP1SMN1; SMN2TSHRMAPK1 | |
| SCHEMBL30686702 | 1.00 | ALDH1A1 (0.76) | ALDH1A1TDP1SMN1; SMN2TSHRMAPK1 | |
| SCHEMBL258034 | 1.00 | ALDH1A1 (0.76) | ALDH1A1TDP1SMN1; SMN2TSHRMAPK1 | |
| SCHEMBL29965332 | 1.00 | ALDH1A1 (0.76) | ALDH1A1TDP1SMN1; SMN2TSHRMAPK1 | |
| SCHEMBL1374973 | 1.00 | ALDH1A1 (0.76) | ALDH1A1TDP1SMN1; SMN2TSHRMAPK1 | |
| SCHEMBL258051 | 1.00 | ALDH1A1 (0.76) | ALDH1A1TDP1SMN1; SMN2TSHRMAPK1 | |
| SCHEMBL25260551 | 1.00 | ALDH1A1 (0.76) | ALDH1A1TDP1SMN1; SMN2TSHRMAPK1 | |
| SCHEMBL258197 | 1.00 | ALDH1A1 (0.76) | ALDH1A1TDP1SMN1; SMN2TSHRMAPK1 | |
| SCHEMBL258237 | 1.00 | ALDH1A1 (0.76) | ALDH1A1TDP1SMN1; SMN2TSHRMAPK1 | |
| SCHEMBL10946638 | 1.00 | ALDH1A1 (0.76) | ALDH1A1TDP1SMN1; SMN2TSHRMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4716679-A2 | AGRICULTURAL COMPOSITION COMPRISING SURFACTANT(S) AND METHOD OF USE THEREOF | Hercules LLC (US) | 2026-04-01 | — | — | EP | claimed |
| EP-4532585-A1 | SURFACTANT COMPRISING POLYOL/ MONOOL - EPOXY PRODUCTS AND ITS PROCESS FOR PREPARATION, COMPOSITION AND METHOD OF USE THEREOF | Hercules LLC (US) | 2025-04-09 | — | — | EP | claimed |
| WO-2024243419-A2 | AGRICULTURAL COMPOSITION COMPRISING SURFACTANT(S) AND METHOD OF USE THEREOF | HERCULES LLC (US) | 2024-11-28 | — | — | WO | claimed |
| WO-2023230470-A1 | SURFACTANT COMPRISING POLYOL/ MONOOL - EPOXY PRODUCTS AND ITS PROCESS FOR PREPARATION, COMPOSITION AND METHOD OF USE THEREOF | HERCULES LLC (US) | 2023-11-30 | — | — | WO | claimed |
| EP-4716679-A2 | AGRICULTURAL COMPOSITION COMPRISING SURFACTANT(S) AND METHOD OF USE THEREOF | Hercules LLC (US) | 2026-04-01 | — | — | EP | disclosed |
| EP-4532585-A1 | SURFACTANT COMPRISING POLYOL/ MONOOL - EPOXY PRODUCTS AND ITS PROCESS FOR PREPARATION, COMPOSITION AND METHOD OF USE THEREOF | Hercules LLC (US) | 2025-04-09 | — | — | EP | disclosed |
| WO-2024243419-A2 | AGRICULTURAL COMPOSITION COMPRISING SURFACTANT(S) AND METHOD OF USE THEREOF | HERCULES LLC (US) | 2024-11-28 | — | — | WO | disclosed |
| WO-2023230470-A1 | SURFACTANT COMPRISING POLYOL/ MONOOL - EPOXY PRODUCTS AND ITS PROCESS FOR PREPARATION, COMPOSITION AND METHOD OF USE THEREOF | HERCULES LLC (US) | 2023-11-30 | — | — | WO | disclosed |
| US-7968607-B2 | Cosmetics 1-isostearylglycerol-3-Sulfate Sodium Salt, used for constriction of keratinocytes; aging resistance | KOA CORPORATION (JP) | 2011-06-28 | — | — | US | disclosed |
| EP-1325737-B1 | SKIN PORE MINIMIZERS AND SKIN ELASTICITY IMPROVERS | KAO CORP (JP) | 2009-12-16 | — | — | EP | disclosed |
| US-20080234390-A1 | SKIN PORE MINIMIZERS AND SKIN ELASTICITY IMPROVERS | KAO CORPORATION (JP) | 2008-09-25 | — | — | US | disclosed |
| US-20040009140-A1 | Skin pore minimizers and skin elasticity improvers | KAO CORPORATION (JP) | 2004-01-15 | — | — | US | disclosed |
| US-5932755-A | Fatty acid ester of etherified polyhydric alcohol | KAO CORPORATION (JP) | 1999-08-03 | — | — | US | disclosed |
| EP-0765862-A1 | FATTY ACID ESTER OF ETHERIFIED POLYHYDRIC ALCOHOL | Kao Corporation (JP) | 1997-04-02 | — | — | EP | disclosed |
| US-4543258-A | EMULSIFIER | KAO CORPORATION (JP) | 1985-09-24 | — | — | US | disclosed |
| US-4504464-A | 2,3-Dialkoxypropyl glyceryl ether and its preparation process as well as cosmetic composition containing same | KAO SOAP CO., LTD. (JP) | 1985-03-12 | — | — | US | disclosed |
| US-4465869-A | Process for the production of glyceryl ethers | KAO CORPORATION (JP) | 1984-08-14 | — | — | US | disclosed |
| US-4465866-A | Preparation process of 2-hydroxy-3-alkoxypropylglyceryl ether | KAO SOAP CO., LTD. (JP) | 1984-08-14 | — | — | US | disclosed |
| EP-0071019-B1 | 2,3-DIALKOXYPROPYL GLYCERYL ETHER AND ITS PREPARATION PROCESS AS WELL AS COSMETIC COMPOSITION CONTAINING SAME | KAO SOAP COMPANY, LTD. (JP) | 1984-05-30 | — | — | EP | disclosed |
| EP-0071019-A1 | 2,3-Dialkoxypropyl glyceryl ether and its preparation process as well as cosmetic composition containing same | KAO SOAP COMPANY, LTD. (JP) | 1983-02-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040009140-A1 | Skin pore minimizers and skin elasticity improvers | CUTA, DSG1, OGA | ALDH1A1 3418/4885TDP1 1595/4885SMN1; SMN2 4367/4885 |
| US-20080234390-A1 | SKIN PORE MINIMIZERS AND SKIN ELASTICITY IMPROVERS | DSG1, CUTA, OGA | ALDH1A1 3613/4885TDP1 2549/4885SMN1; SMN2 4395/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.